> About the Conference
"Our vision is to establish BioVaria as Europe’s premier marketplace for cutting-edge, licensable technologies from publicly-funded life-science research."
BioVaria was originally established as a nationwide biopharmaceutical showcasing event presenting top licensing opportunities from a broad range of public research institutions and universities to the international industry. The concept received a strong positive response from research, technology transfer and industry: In 2008, over 150 delegates participated, many interactions were initiated and most of these are still ongoing, first deals have been closed and a start-up founded. Building on these results, the organizers were able to broaden the range of participating technology transfer organisations and potential licensees in 2009. In 2010, BioVaria provides, for the first time, access to technology transfer partners from all over Europe.
Also new in 2010 will be the Spin-Off Marketplace , introducing some of Europe’s most promising entrepreneurial biotech companies to life-science investors and business developers.
BioVaria is organized by Ascenion GmbH, an IP asset management company exclusively focused on the life sciences, together with a broad range of technology transfer organizations.